Twin Peaks Wealth Advisors, LLC Biotechnology

Twin Peaks Wealth Advisors, LLC

$309 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
ATOS Atossa Therapeutics, Inc.	$97.5M	$77,000 0.0% of portfolio	100	Q2 2025 New
ACLX Arcellx, Inc.	$3.19B	$73,000 0.0% of portfolio	1	Q2 2025 New
CDTX Cidara Therapeutics, Inc.	$4.34B	$62,000 0.0% of portfolio	1	Q2 2025 New
TARS Tarsus Pharmaceuticals, Inc.	$1.37B	$51,000 0.0% of portfolio	1	Q2 2025 New
ALT Altimmune, Inc.	$177M	$47,000 0.0% of portfolio	13	Q2 2025 New
IMVT Immunovant, Inc.	$3.55B	$46,000 0.0% of portfolio	3	Q2 2025 New
URGN Uro Gen Pharma Ltd.	$437M	$38,000 0.0% of portfolio	2	Q2 2025 New
XENE Xenon Pharmaceuticals Inc.	$2.24B	$36,000 0.0% of portfolio	1	Q2 2025 New
WVE Wave Life Sciences Ltd.	$734M	$34,000 0.0% of portfolio	4	Q2 2025 New
ARQT Arcutis Biotherapeutics, Inc.	$887M	$29,000 0.0% of portfolio	2	Q2 2025 New
OCUL Ocular Therapeutix, Inc	$961M	$25,000 0.0% of portfolio	2	Q2 2025 New
AUPH Aurinia Pharmaceuticals Inc.	$1.61B	$23,000 0.0% of portfolio	2	Q2 2025 New
RXRX Recursion Pharmaceuticals, Inc.	$976M	$22,000 0.0% of portfolio	4	Q2 2025 New
SRPT Sarepta Therapeutics, Inc.	$1.6B	$19,000 0.0% of portfolio	1	Q2 2025 New
TVTX Travere Therapeutics, Inc.	$1.12B	$17,000 0.0% of portfolio	1	Q2 2025 New
TRVI Trevi Therapeutics, Inc.	$428M	$15,000 0.0% of portfolio	2	Q2 2025 New
EYPT Eye Point Pharmaceuticals, Inc.	$366M	$11,000 0.0% of portfolio	1	Q2 2025 New
AVXL Anavex Life Sciences Corp.	$840M	$11,000 0.0% of portfolio	1	Q2 2025 New
NRIX Nurix Therapeutics, Inc.	$472M	$10,000 0.0% of portfolio	1	Q2 2025 New
TNGX Tango Therapeutics, Inc.	$595M	$7,000 0.0% of portfolio	1	Q2 2025 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Peaks Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Twin Peaks Wealth Advisors, LLC with notifications on news.